Sevion Therapeutics Inc Share Price OTC Bulletin Board
Equities
US81834Q1040
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 2.97M 235M |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 * | - |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-0.11
x | P/E ratio 2024 * |
-0.12
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 95.63% |
Latest transcript on Sevion Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Sumit Aggarwal
CEO | Chief Executive Officer | - | 31/03/21 |
Daniel Geffken
DFI | Director of Finance/CFO | 67 | 31/10/20 |
Ali Hariri
CTO | Chief Tech/Sci/R&D Officer | - | 07/09/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Rubin
BRD | Director/Board Member | 63 | 30/04/14 |
Alan Walts
BRD | Director/Board Member | 64 | 31/03/21 |
Sumit Aggarwal
CEO | Chief Executive Officer | - | 31/03/21 |
1st Jan change | Capi. | |
---|---|---|
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.41% | 21.25B | |
-5.48% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+37.57% | 12.54B | |
-26.24% | 8.09B |